MedPath

SUPERvised Three-month Exercise Program in MEN With Prostate cAncer Receiving Androgen-deprivaTioN thERapy

Not Applicable
Suspended
Conditions
Prostatic Neoplasms
Metastasis
Registration Number
NCT06282185
Lead Sponsor
Canisius-Wilhelmina Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

Inclusion Criteria:<br><br> - Signed informed consent<br><br> - Age > 18 years old<br><br> - Able to read and complete questionnaires in Dutch<br><br> - Proven histologically and /or radiologically metastatic prostate cancer (TxNxM1)<br><br>Exclusion Criteria:<br><br> - Other cancers<br><br> - Clinicians' judgement<br><br> - Age >80 years old or not able to walk 400m<br><br> - Structural exercise (moderate-intensity exercise more than 150 minutes a week)<br> during the past 3 months<br><br> - Musculoskeletal, cardiovascular, or neurological disorders that could inhibit them<br> from exercising<br><br> - Spinal cord compression, history of pathological fractures

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
change of quality of life assessed with EPIC26 (0-100 points);change of quality of life assessed with EPIC26 (0-100 points);change of quality of life assessed with EORTC QLQ-C30 (0-100 points per scale);change of quality of life assessed with EORTC QLQ-C30 (0-100 points per scale)
Secondary Outcome Measures
NameTimeMethod
change of physical fitness in maximum uptake of oxygen in ml/kg/min;change of physical fitness in maximum uptake of oxygen in ml/kg/min;change of physical fitness in fat percentage;change of physical fitness in fat percentage;change of fitness assessed with IPAQ-sh (categories (1-3) and continues (MET-minutes));change of fitness assessed with IPAQ-sh (categories (1-3) and continues (MET-minutes))
© Copyright 2025. All Rights Reserved by MedPath